transformation related protein 53, pseudogene ; Mus musculus






3044 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
251 9717829 Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control. Clin Cancer Res 1998 Aug 1
252 9719461 p53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages. Cancer Lett 1998 Jul 17 11
253 9731488 High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele. Cancer Res 1998 Sep 1 4
254 9731495 Irreversible G2-M arrest and cytoskeletal reorganization induced by cytotoxic nucleoside analogues. Cancer Res 1998 Sep 1 1
255 9738462 p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment. FEBS Lett 1998 Aug 28 2
256 9751125 Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Differ 1998 Sep 3
257 9780227 Butylated hydroxytoluene modulates DNA methylation in rats. Eur J Biochem 1998 Sep 15 1
258 9795126 Distinct mode of apoptosis induced by genotoxic agent etoposide and serum withdrawal in neuroblastoma cells. Brain Res Mol Brain Res 1998 Nov 12 1
259 9796694 Inhibition of p53-dependent apoptosis by the KIT tyrosine kinase: regulation of mitochondrial permeability transition and reactive oxygen species generation. Oncogene 1998 Oct 1 4
260 9808574 Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53. Blood 1998 Nov 15 1
261 9816169 Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint. Clin Cancer Res 1996 Feb 4
262 9834241 CBFbeta-SMMHC, expressed in M4eo acute myeloid leukemia, reduces p53 induction and slows apoptosis in hematopoietic cells exposed to DNA-damaging agents. Blood 1998 Dec 1 1
263 9839726 Kainic acid-induced neuronal loss and glial changes in the hippocampal CA3 of p53-deficient mouse. Neurosci Lett 1998 Oct 9 1
264 9840938 Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity. Oncogene 1998 Nov 26 1
265 9843859 Alveolar macrophage apoptosis and TNF-alpha, but not p53, expression correlate with murine response to bleomycin. Am J Physiol 1998 Dec 1
266 9849426 p53 expression in skin carcinogenesis and its relationship to cell proliferation and tumour growth. Eur J Cancer 1998 Aug 4
267 9850078 Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis. Cancer Res 1998 Dec 1 2
268 9850079 The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res 1998 Dec 1 7
269 9851850 p53-mediated germ cell quality control in spermatogenesis. Dev Biol 1998 Dec 1 1
270 9856857 Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons. J Neurosci Res 1998 Dec 15 1
271 9858902 p53, Bax and Bcl-2 in vivo expression in the murine thymus after apoptogenic treatments. Anticancer Res 1998 Sep-Oct 1
272 9872997 Cellular protection mechanisms against extracellular heme. heme-hemopexin, but not free heme, activates the N-terminal c-jun kinase. J Biol Chem 1999 Jan 8 1
273 9880587 A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. J Neurosci 1999 Jan 15 1
274 9892179 Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts. Cancer Res 1999 Jan 1 1
275 10022227 Chemically-induced apoptosis: p21 and p53 as determinants of enterotoxin activity. Toxicol Lett 1998 Dec 28 4
276 10081609 The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53. Cell Mol Neurobiol 1999 Apr 5
277 10082513 Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol Cell Biol 1999 Apr 3
278 10094408 Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable. Mol Cell Biochem 1999 Jan 5
279 10096421 Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Lett 1999 Jan 29 1
280 10098976 Growing and differentiating characterization of aortic smooth muscle cell line, p53LMAC01 obtained from p53 knock out mice. Mol Cell Biochem 1999 Jan 2
281 10187847 Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53. J Biol Chem 1999 Apr 9 2
282 10200338 Effect of doxorubicin on wild-type and deoxyadenosine-resistant mouse leukemia L1210 cells. Int J Oncol 1999 May 2
283 10200488 Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance. Cell Death Differ 1998 May 1
284 10222137 An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp Cell Res 1999 May 1 1
285 10223204 LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Carcinogenesis 1999 Apr 2
286 10223621 Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells. Oncol Res 1998 4
287 10226577 p53-independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines. Anticancer Res 1999 Jan-Feb 4
288 10321741 Suppression of Ras-mediated NIH3T3 transformation by p19ARF does not involve alterations of cell growth properties. Oncogene 1999 Mar 25 1
289 10339661 Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells. Int J Oncol 1999 Jun 1
290 10354508 The relationship of p53 and stress proteins in response to bleomycin and retinoic acid in the p53 heterozygous mouse. Biochim Biophys Acta 1999 Jun 8 6
291 10358069 DNA-dependent protein kinase-independent activation of p53 in response to DNA damage. J Biol Chem 1999 Jun 11 1
292 10359011 p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression. Cell Growth Differ 1999 May 3
293 10373675 Tissue-specific expression of the p53 tumor-suppressor gene in the intestine of transgenic mice exposed to DMH and p53 antibodies. Oncol Rep 1999 Jul-Aug 3
294 10395176 Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity. Cancer Lett 1999 May 24 1
295 10403253 DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 1999 Jul 1 1
296 10404639 Determination of mRNA, and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin. Int J Biochem Cell Biol 1999 Jun 12
297 10425208 The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53. Biochem Biophys Res Commun 1999 Aug 2 3
298 10432310 Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. Biochem J 1999 Aug 15 2
299 10435582 Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. Immunity 1999 Jul 1
300 10435642 Modulations of glucocorticoid-induced apoptosis linked to the p53 deletion and to the apoptosis susceptibility gene Rapop1 (Radiation-induced apoptosis 1). Oncogene 1999 Jul 22 2